Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Dolby Laboratories, Inc. (DLB)
|
Add to portfolio |
|
|
|
| Price: |
$95.86
| | Metrics |
| OS: |
95.6
|
M
| |
|
|
| Market cap: |
$9.17
|
B
| |
|
|
|
Net cash:
|
$987
|
M
| |
$10.32
|
per share
|
|
EV:
|
$8.18
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$284
|
M
| |
28.8
|
x EV/EBITDA
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Sep-30-22 | Sep-24-21 | Sep-25-20 | Sep-27-19 | Sep-28-18 | Sep-29-17 | Sep-30-16 | Sep-25-15 |
| Revenues | 1,253.8 | 1,281.3 | 1,161.8 | 1,241.6 | 1,054.6 | 1,080.2 | 1,025.7 | 970.6 |
| Revenue growth | -2.1% | 10.3% | -6.4% | 17.7% | -2.4% | 5.3% | 5.7% | 1.1% |
| Cost of goods sold | 141.4 | 130.0 | 146.5 | 160.9 | 127.6 | 118.5 | 109.0 | 94.8 |
| Gross profit | 1,112.4 | 1,151.2 | 1,015.3 | 1,080.8 | 927.0 | 961.6 | 916.8 | 875.8 |
| Gross margin | 88.7% | 89.9% | 87.4% | 87.0% | 87.9% | 89.0% | 89.4% | 90.2% |
| Selling, general and administrative | | | | | | | | |
| Sales and marketing | 358.7 | 332.7 | 335.9 | 343.8 | 309.8 | 296.7 | 295.3 | 279.2 |
| Research and development | 261.2 | 253.6 | 239.0 | 237.9 | 236.8 | 233.3 | 219.6 | 201.3 |
| General and administrative | 275.3 | 224.2 | 219.8 | 205.4 | 197.4 | 171.7 | 168.9 | 182.2 |
| EBITA | 225.0 | 363.7 | 246.4 | 250.2 | 210.5 | 265.2 | 263.8 | 234.1 |
| EBITA margin | 17.9% | 28.4% | 21.2% | 20.2% | 20.0% | 24.5% | 25.7% | 24.1% |
| Amortization of intangibles | 29.0 | 29.5 | 29.5 | 29.7 | 26.5 | 30.9 | 33.2 | 21.0 |
| EBIT | 196.0 | 334.2 | 216.9 | 220.5 | 184.0 | 234.3 | 230.6 | 213.1 |
| EBIT margin | 15.6% | 26.1% | 18.7% | 17.8% | 17.4% | 21.7% | 22.5% | 22.0% |
| Pre-tax income | 215.3 | 354.5 | 239.7 | 282.3 | 196.4 | 255.1 | 235.9 | 245.8 |
| Income taxes | 31.4 | 36.7 | 8.1 | 26.8 | 154.1 | 48.0 | 49.5 | 62.5 |
| Tax rate | 14.6% | 10.3% | 3.4% | 9.5% | 78.5% | 18.8% | 21.0% | 25.4% |
| Net income | 184.1 | 310.2 | 231.4 | 255.2 | 41.7 | 206.5 | 185.9 | 181.4 |
| Net margin | 14.7% | 24.2% | 19.9% | 20.5% | 4.0% | 19.1% | 18.1% | 18.7% |
| |
| Diluted EPS | $1.81 | $2.97 | $2.25 | $2.44 | $0.39 | $2.00 | $1.81 | $1.75 |
| Shares outstanding (diluted) | 102.0 | 104.6 | 102.9 | 104.6 | 107.0 | 103.3 | 102.4 | 103.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|